209 related articles for article (PubMed ID: 34139048)
1. Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review.
Christensen J; O'Callaghan K; Sinclair H; Hawke K; Love A; Hajkowicz K; Stewart AG
Intern Med J; 2022 Apr; 52(4):522-529. PubMed ID: 34139048
[TBL] [Abstract][Full Text] [Related]
2. The association of subacute thyroiditis with viral diseases: a comprehensive review of literature.
Rafiei N; Masoudi M; Jadidi H; Ghaedi A; Jahani N; Ebrahimi S; Gharei F; Amirhoushangi H; Bayat M; Ansari A; Faal Hamedanchi N; Hosseini P; Elmi S; Garousi S; Mottahedi M; Ghasemi M; Alizadeh A; Deravi N
Przegl Epidemiol; 2023; 77(2):136-145. PubMed ID: 37823628
[TBL] [Abstract][Full Text] [Related]
3. Comparison of treatment outcome between glucocorticoids and non-steroidal anti-inflammatory drugs in subacute thyroiditis patients-a systematic review and meta-analysis.
Yuan A; Wu J; Huang H
Front Endocrinol (Lausanne); 2024; 15():1384365. PubMed ID: 38715797
[TBL] [Abstract][Full Text] [Related]
4. Subacute thyroiditis following COVID-19 vaccination: Case presentation.
Tomic AZ; Zafirovic SS; Gluvic ZM; Samardzic VS; Macvanin MT; Radunovic ML; Isenovic ER
Antivir Ther; 2023 Oct; 28(5):13596535231208831. PubMed ID: 37861754
[No Abstract] [Full Text] [Related]
5. Case report: Neglected subacute thyroiditis: a case following COVID-19 vaccination.
Yang S; Guan T; Yang H; Hu Y; Zhao Y
Front Med (Lausanne); 2024; 11():1349615. PubMed ID: 38523906
[TBL] [Abstract][Full Text] [Related]
6. Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity.
Chakraborty U; Ghosh S; Chandra A; Ray AK
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370933
[TBL] [Abstract][Full Text] [Related]
7. SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype.
Silvestri Y; Clemente F; Moschetti G; Maioli S; Carelli E; Espadas de Arias A; Torelli R; Longhi E; De Feo T; Crosti M; Sarnicola ML; Salvi M; Mantovani G; Arosio M; Bombaci M; Pesce E; Grifantini R; Abrignani S; Geginat J; Muller I
Clin Immunol; 2023 Sep; 254():109684. PubMed ID: 37451415
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of patients with subacute thyroiditis.
Kjellerup CR; Thomsen MJ; Torp NMU; Karmisholt J; Andersen SL
Dan Med J; 2023 Oct; 70(11):. PubMed ID: 37897374
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Xiaochaihu decoction for subacute thyroiditis: A protocol of systematic review and meta-analysis.
Li L; Yue R; Zeng L; Wang S; Zhuo W; Sun Y
Medicine (Baltimore); 2020 Nov; 99(46):e23011. PubMed ID: 33181665
[TBL] [Abstract][Full Text] [Related]
10. Subacute thyroiditis after SARS-CoV-2 vaccination: A case report.
Akha O; Mazandarani M; Azari S; Daneshfar N; Rasouli K; Heydari K; Tavakolian G; Hoseini A
Clin Case Rep; 2024 Apr; 12(4):e8678. PubMed ID: 38550739
[TBL] [Abstract][Full Text] [Related]
11. Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study.
De Vincentis S; Loiacono S; Zanni E; Sueri R; Monzani ML; Santi D; Muller I; Di Marco F; Crivicich E; Armenti M; Pagotto U; Tucci L; Cecchetti C; Trenti T; Pecoraro V; Canu G; Simoni M; Brigante G
Eur Thyroid J; 2024 Jun; ():. PubMed ID: 38838198
[TBL] [Abstract][Full Text] [Related]
12. Subacute Thyroiditis Following COVID-19 and COVID-19 Vaccination.
Duskin-Bitan H; Robenshtok E; Peretz A; Beckenstein T; Tsur N; Netzer D; Cohen AD; Saliba W; Shimon I; Gorshtein A
Endocr Pract; 2024 May; ():. PubMed ID: 38729568
[TBL] [Abstract][Full Text] [Related]
13. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives.
Ruggeri RM; Campennì A; Deandreis D; Siracusa M; Tozzoli R; Petranović Ovčariček P; Giovanella L
Expert Rev Clin Immunol; 2021 Jul; 17(7):737-759. PubMed ID: 34015983
[No Abstract] [Full Text] [Related]
14. COVID-19 and Thyroid Diseases: A Bidirectional Impact.
Duntas LH; Jonklaas J
J Endocr Soc; 2021 Aug; 5(8):bvab076. PubMed ID: 34189381
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Autoimmunity and SARS-CoV-2 Infection.
Fallahi P; Elia G; Ragusa F; Paparo SR; Patrizio A; Balestri E; Mazzi V; Benvenga S; Varricchi G; Gragnani L; Botrini C; Baldini E; Centanni M; Ferri C; Antonelli A; Ferrari SM
J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37835009
[TBL] [Abstract][Full Text] [Related]
16. Potential Interaction Between SARS-CoV-2 and Thyroid: A Review.
Chen W; Tian Y; Li Z; Zhu J; Wei T; Lei J
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33543236
[TBL] [Abstract][Full Text] [Related]
17. Clinical Aspects in Subacute Thyroiditis: A Real-Life Study on 226 Cases in Greece Amid the COVID-19 Pandemic.
Angelopoulos N; Askitis DP; Androulakis I; Valvis N; Paparodis R; Petkova V; Boniakos A; Zianni D; Perogamvros I; Toulis K; Livadas S; Iakovou I
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002783
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 and spinal cord ischemia: a systematic review on clinical presentations, diagnosis, treatment, and outcomes.
Sourani A; Vahdat N; Bowers CA; Rezvani M; Foroughi M; Sourani A; Mirza R; Baradaran Mahdavi S
Spine J; 2024 Jun; 24(6):979-988. PubMed ID: 38365009
[TBL] [Abstract][Full Text] [Related]
19. Significance of HLA Haplotypes in Two Patients with Subacute Thyroiditis Triggered by mRNA-Based COVID-19 Vaccine.
Stasiak M; Zawadzka-Starczewska K; Lewiński A
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214738
[TBL] [Abstract][Full Text] [Related]
20. Response to Letter to the Editor From Kleebayoon and Wiuwanikit: "Subacute THYROiditis Related to SARS-CoV-2 Vaccine and COVID-19 (THYROVAC Study): A Multicenter Nationwide Study".
Ağbaht K; Şahin M
J Clin Endocrinol Metab; 2023 Dec; 109(1):e436. PubMed ID: 37554094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
